NLINKN1 Chip+PRIME.StudySYNCRStentrode+$75M.SeriesDPRECNLayer 7+FDA.BrkthruPARAMArgo+$20M.SeriesBBLKRKNeuroport+200.ImplantsEMTIVMN8+$45M.SeriesBKRNLFlux+Non-invasiveNRBLEHalo+Consumer.BCINEURONeuroPace+RNS.SystemCOGNICognixion+ALS.TrialFUND.YTD2026$2.8B.SectorTRIALSActive50+.ClinTrialsIMPLNTSHumans~100.Intracrtnl
Terminal/Device DB/eego mylab
EEG510k-clearedcommercial

eego mylab

Implant Type
EEG
Electrodes
256
Channels
256
FDA Status
510k-cleared
Status
commercial
About

The ANT Neuro eego mylab is a portable, battery-powered research-grade EEG system available in 32, 64, 128, and 256 channel versions. Features active shielding, high input impedance (>1 GΩ), and up to 24-bit resolution with maximum sampling rate of 16,384 Hz across all channels. The cascaded 128/256-channel versions can be split into separate mobile 64-channel systems. Supports 24 bipolar ExG inputs for EMG, respiration, GSR, accelerometer, temperature, and SpO2. 8-bit TTL triggers and LSL support for event synchronization. CE marked medical device with FDA clearance. Compatible with dry and gel-based EEG caps.

Target Conditions
neuroscience researchclinical EEGevoked potentialspolysomnography
FDA Regulatory Pathway
No FDA Regulatory Status

This device does not have a current FDA designation. It may be a research tool, preclinical device, or consumer product not subject to FDA medical device regulation.

FDA Device Regulatory Guidance ↗
Other EEG Devices